# Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea

> **NCT01596829** · PHASE2,PHASE3 · TERMINATED · sponsor: **Danisco** · enrollment: 258 (actual)

## Conditions studied

- Antibiotic-associated Diarrhoea

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01596829
- **Lead sponsor:** Danisco
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 258 (ACTUAL)
- **Why stopped:** low incidence
- **Last updated:** 2016-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596829, "Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01596829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*